163 related articles for article (PubMed ID: 11183928)
1. Regulatory and legislative challenges facing managed care.
Giaquinta D
Manag Care Interface; 2000 Jul; 13(7):47-9. PubMed ID: 11183928
[No Abstract] [Full Text] [Related]
2. Pharmaceuticals issue brief: managed care drug formularies: year end report-2003.
MacEachern L
Issue Brief Health Policy Track Serv; 2003 Dec; ():1-8. PubMed ID: 14969259
[TBL] [Abstract][Full Text] [Related]
3. Legislative challenges facing managed care pharmacy.
Epstein L
Manag Care Interface; 1997 Oct; 10(10):92-4, 98. PubMed ID: 10174422
[No Abstract] [Full Text] [Related]
4. Confidentiality of prescription drug information in the era of computers and managed care. McDonald-Merrill-Ketcham lecture.
Lo B
Spec Law Dig Health Care Law; 2001 Jun; (266):9-27. PubMed ID: 11434346
[No Abstract] [Full Text] [Related]
5. Pharmaceutical formularies: the right formula for cost and utilization?
Austin B
Find Brief; 2004 Aug; 7(5):1-3. PubMed ID: 15298009
[No Abstract] [Full Text] [Related]
6. PBMs and a Medicare prescription drug benefit.
Cohen JP
Food Drug Law J; 2000; 55(3):311-20. PubMed ID: 11824463
[No Abstract] [Full Text] [Related]
7. Medicare risk programs and pharmacy benefits managers.
Herzfeld J
Med Interface; 1996 Dec; 9(12):75-8. PubMed ID: 10172875
[TBL] [Abstract][Full Text] [Related]
8. Strategic choices for managed care plans under the Modernization Act of 2003.
Shekhdar AR
J Health Law; 2004; 37(3):429-44. PubMed ID: 15648536
[TBL] [Abstract][Full Text] [Related]
9. Cost not the primary factor driving drug coverage.
Capitation Rates Data; 2000 May; 5(5):51-3. PubMed ID: 11066970
[No Abstract] [Full Text] [Related]
10. Rebates and other drug-cost issues.
Penna P
Manag Care Interface; 2003 May; 16(5):39-40. PubMed ID: 12789863
[No Abstract] [Full Text] [Related]
11. Pharmacy benefit management as a quality safeguard.
Giaquinta D
Manag Care Interface; 2002 Mar; 15(3):54, 57. PubMed ID: 11925680
[No Abstract] [Full Text] [Related]
12. The FDA's regulation of pharmaceutical communications in the context of managed care: a suggested approach.
Kuhlik BN
Food Drug Law J; 1995; 50(1):23-48. PubMed ID: 10342984
[No Abstract] [Full Text] [Related]
13. HIPAA modifications ease burdens, but don't take anything for granted.
Fox SJ; Wilson RH; Jones JW
Manag Care; 2002 Nov; 11(11):56-7. PubMed ID: 12491860
[No Abstract] [Full Text] [Related]
14. Managed care cost containment involving prescription drugs. American Medical Association, Council on Ethical and Judicial Affairs.
Food Drug Law J; 1998; 53(1):25-34. PubMed ID: 11795334
[No Abstract] [Full Text] [Related]
15. Managed care organizations and confidential patient information: the need for a uniform standard.
Weissburg DJ
J Health Care Finance; 1995; 21(4):42-6. PubMed ID: 7583782
[TBL] [Abstract][Full Text] [Related]
16. Protecting confidentiality & improving health.
Coleman D
Healthplan; 1998; 39(6):38-43. PubMed ID: 10351346
[No Abstract] [Full Text] [Related]
17. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
Chaps NA
Issue Brief Health Policy Track Serv; 2010 Jan; ():1-19. PubMed ID: 20213917
[No Abstract] [Full Text] [Related]
18. Advancing economic evaluations of drug therapy.
Navarro RP
Med Interface; 1996 Jul; 9(7):86-7, 92. PubMed ID: 10159281
[No Abstract] [Full Text] [Related]
19. Cut pharmaceutical costs, but mind the legal dangers.
Abood RR
Manag Care; 1997 Aug; 6(8):47-8, 51-4. PubMed ID: 10170246
[No Abstract] [Full Text] [Related]
20. Plans ready to go all out for Part D.
Carroll J
Manag Care; 2005 Oct; 14(10):16, 19. PubMed ID: 16277188
[No Abstract] [Full Text] [Related]
[Next] [New Search]
